ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,985Medicare Part D Prescriptions Filled, Including Refills

Rank: 296 out of 1844

$590K Total Retail Price of All Prescriptions

Rank: 240 out of 1844

457 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 457 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 457 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 7,590 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 445 406 1 3
LEVOTHYROXINE SODIUM 401 349 2 1
HYDROCODONE-ACETAMINOPHEN 392 295 S3 3 2
LISINOPRIL 284 254 4 4
AMLODIPINE BESYLATE 275 271 5 6
OMEPRAZOLE 264 235 6 5
CITALOPRAM HBR 166 142 7 19
METFORMIN HCL 162 125 8 8
FUROSEMIDE 161 132 9 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 151 150 10 20
METOPROLOL TARTRATE 139 131 11 11
GABAPENTIN 126 107 12 15
ATENOLOL 120 99 13 17
PRAVASTATIN SODIUM 103 85 14 10
LOSARTAN POTASSIUM 100 96 15 24
CELEBREX 100 87 15 91
PREDNISONE 98 86 17 40
METOPROLOL SUCCINATE 97 83 18 14
SPIRIVA 94 91 19 57
OXYCODONE HCL-ACETAMINOPHEN 92 71 S2 20 83
SERTRALINE HCL 87 73 21 21
TRAZODONE HCL 83 69 22 43
AZITHROMYCIN 83 77 22 37
ATORVASTATIN CALCIUM 83 68 22 12
TRAMADOL HCL 80 61 25 18
WARFARIN SODIUM 78 65 26 13
CARVEDILOL 75 75 27 22
PROAIR HFA 73 51 28 45
ROPINIROLE HCL 73 37 28 76
EVISTA 72 72 30 95
ADVAIR DISKUS 71 54 31 51
PANTOPRAZOLE SODIUM 69 55 32 32
TAMSULOSIN HCL 69 47 32 27
CLOPIDOGREL 67 53 34 34
FLUOXETINE HCL 66 63 35 41
GLIMEPIRIDE 66 64 35 35
AMOXICILLIN 65 55 37 101
NEXIUM 65 50 37 31
PLAVIX 63 55 39 61
DIOVAN 62 59 40 58
LANTUS 61 49 41 42
CLONIDINE HCL 61 59 41 64
ESCITALOPRAM OXALATE 60 40 43 52
LOVASTATIN 60 46 43 44
ALLOPURINOL 60 60 43 29
ZOLPIDEM TARTRATE 59 53 46 23
HYDROCHLOROTHIAZIDE 56 55 47 9
CYMBALTA 54 43 48 36
LANTUS SOLOSTAR 51 35 49 97
NAMENDA 51 51 49 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.